Latest Breaking News On - Alto neuroscience - Page 9 : vimarsana.com

ArriVent brings in $175M for biotech s second IPO of the year

ArriVent brings in $175M for biotech s second IPO of the year
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Arrivent biopharmaAlto neuroscience

ArriVent s Nasdaq Debut Nabs $175M as Signs Indicate an Opening IPO Window

ArriVent BioPharma will apply the IPO cash toward furmonertinib, which the biotech says could offer advantages over Takeda Pharmaceutical and Johnson & Johnson drugs that address the same lung cancer target. It’s the second biotech IPO of this week, following CG Oncology.

Arrivent biopharmaJohnson rybrevantAllist pharmaNewtown squareFederal reservePennsylvania based arriventShanghai based allistAlto neuroscienceMetagenomi technologiesWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciences

Early IPO Activity Could Spell Bullishness for Biotech Industry

Early IPO Activity Could Spell Bullishness for Biotech Industry
etftrends.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etftrends.com Daily Mail and Mail on Sunday newspapers.

Arrivent biopharmaPricewaterhousecoopers pwSelect industry indexAlto neuroscienceKyverna therapeuticsDirexion daily sp biotech bullDirexion daily sp biotech bear

CG Oncology prices larger-than-expected $380M IPO in hopeful sign for biotech

BioPharma

Arrivent biopharmaKazi helalMerck coFederal reserveWall streetBiopharma diveAlto neuroscienceMichael romeForesite capital

Kyverna accelerates into another FDA fast track

Kyverna accelerates into another FDA fast track
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

David porterUniversity of pennsylvaniaAlto neuroscience